Literature DB >> 1375111

Mutations of p53 gene and their relation to disease progression in B-cell lymphoma.

A Ichikawa1, T Hotta, N Takagi, K Tsushita, T Kinoshita, H Nagai, Y Murakami, K Hayashi, H Saito.   

Abstract

The alteration of p53 tumor suppressor gene was studied in 48 patients with B-cell lymphoma. A sequential combined technique of polymerase chain reaction-mediated single-strand conformational polymorphism (PCR-SSCP) or reverse transcription (RT)-PCR-SSCP and direct sequencing were used as a simple and sensitive approach to analyze nucleotide changes. By these methods, we identified 8 missense point mutations and 2 codon deletions in 9 of the 48 patients. These mutations were located in or close to the evolutionally highly conserved regions of the p53 gene. Eight of nine patients having p53 gene alterations were in advanced clinical stage (IV). It is the first report of p53 gene mutations in follicular and diffuse lymphoma. These observations suggest that the p53 gene alteration may play an important role in lymphomagenesis and/or disease progression in some types of B-cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375111

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  Richter's transformation in chronic lymphocytic leukemia.

Authors:  Apostolia-Maria Tsimberidou; Michael J Keating; William G Wierda
Journal:  Curr Hematol Malig Rep       Date:  2007-10       Impact factor: 3.952

2.  Homozygous deletion of INK4a/ARF genes and overexpression of bcl-2 in relation with poor prognosis in immunocompetent patients with primary central nervous system lymphoma of the diffuse large B-cell type.

Authors:  Y Hayashi; M Iwato; Y Arakawa; H Fujisawa; Y Thoma; M Hasegawa; O Tachibana; J Yamashita
Journal:  J Neurooncol       Date:  2001-10       Impact factor: 4.130

3.  Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.

Authors:  A Matolcsy; P Casali; R G Nádor; Y F Liu; D M Knowles
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

4.  Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.

Authors:  Junji Hiraga; Tomohiro Kinoshita; Toshihito Ohno; Naoyoshi Mori; Haruhiko Ohashi; Shouko Fukami; Atsuhiko Noda; Atsushi Ichikawa; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

5.  P53 gene mutations in non-Hodgkin's lymphoma.

Authors:  Y Chen; Z Xiang; H Li; N Yang; H Zhang
Journal:  J Tongji Med Univ       Date:  1999

6.  High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma.

Authors:  E Cesarman; G Inghirami; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas.

Authors:  R H Edwards; N Raab-Traub
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Absence of p53 mutation in Japanese patients with malignant thyroid lymphoma.

Authors:  K Iyota; K Takeda; F Matsuzuka; T Okabayashi; S Morita; K Kuma; K Hashimoto
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

9.  Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.

Authors:  A Y Matsushima; E Cesarman; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

10.  Analysis of the p53 gene mutations in acute myelogenous leukemia: the p53 gene mutations associated with a deletion of chromosome 17.

Authors:  M Kurosawa; M Okabe; Y Kunieda; M Asaka
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.